Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	Placebo	26
Overall Study	STARTED	Avenciguat 2 mg BID	27
Overall Study	STARTED	Avenciguat 3 mg BID	27
Overall Study	Treated	Placebo	25
Overall Study	Treated	Avenciguat 2 mg BID	27
Overall Study	Treated	Avenciguat 3 mg BID	27
Overall Study	COMPLETED	Placebo	19
Overall Study	COMPLETED	Avenciguat 2 mg BID	23
Overall Study	COMPLETED	Avenciguat 3 mg BID	17
Overall Study	NOT COMPLETED	Placebo	7
Overall Study	NOT COMPLETED	Avenciguat 2 mg BID	4
Overall Study	NOT COMPLETED	Avenciguat 3 mg BID	10

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT05161481/flow